Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -25.56x is 38% above its 2-year average of -41.27x, near the high end of its 2-year range (-213.29x–-13.12x).
49.86% below its 12-month average of -17.06x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2025 (2026-03-31): -13.21x.
INTEREST COVERAGE RATIO
-25.56x
INTEREST COVERAGE RATIO AVG TTM
-17.06x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-49.86%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
-353.59%
vs the sector median at left
Lunai Bioworks Inc.
Market Cap
$5.21M
Interest Coverage Ratio
-25.56x
TTM Avg
-17.06x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.27M
Interest Coverage Ratio
-1174.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.17M
Interest Coverage Ratio
-13.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.29M
Interest Coverage Ratio
1324.50x
TTM Avg
1324.50x
3Y Avg
1324.50x
5Y Avg
1324.50x
Market Cap
$5.20M
Interest Coverage Ratio
-10.70x
TTM Avg
10.43x
3Y Avg
9.52x
5Y Avg
9.52x
Market Cap
$5.14M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.72M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lunai Bioworks Inc. (LNAI) | $5.21M | -25.56x | -17.06x | N/A | N/A |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | N/A | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | -1174.37x | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.19M | N/A | 1.00x | 1.02x | 1.02x |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | -13.75x | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 1324.50x | 1324.50x | 1324.50x | 1324.50x |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | -10.70x | 10.43x | 9.52x | 9.52x |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.14M | -2.90x | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.72M | -16.26x | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.59M | N/A | N/A | N/A | N/A |
Interest Coverage
-25.6x
Debt/Equity
N/A
Current Ratio
0.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -13.21x |
| 2025-12-31 | -15.01x |
| 2025-09-30 | -13.12x |
| 2025-06-30 | -21.88x |
| 2025-03-31 | -22.06x |
| 2024-12-31 | -39.17x |
| 2024-09-30 | -213.29x |
| 2024-06-30 | -30.59x |
| 2024-03-31 | -28.87x |
| 2023-12-31 | -15.53x |
